Cedar Knolls, NJ, United States of America

Lakshman Jayanth Parthiban

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Novartis Ag. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lakshman Jayanth Parthiban. Retrieved from https://idiyas.com/inventor/lakshman-jayanth-parthiban

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lakshman Jayanth Parthiban: Innovator in Pharmaceutical Formulations

Introduction

Lakshman Jayanth Parthiban is a notable inventor based in Cedar Knolls, NJ (US). He has made significant contributions to the field of pharmaceutical formulations. His innovative work focuses on improving the delivery and effectiveness of pharmaceutical active ingredients.

Latest Patents

Lakshman holds 1 patent for a pharmaceutical formulation. This patent provides processes for making and forms of solid dispersions of pharmaceutical active ingredients. His invention aims to enhance the solubility and bioavailability of drugs, which is crucial for effective treatment.

Career Highlights

Lakshman is currently employed at Novartis AG, a leading global healthcare company. His role involves research and development in the pharmaceutical sector, where he applies his expertise to create innovative solutions for complex medical challenges.

Collaborations

Throughout his career, Lakshman has collaborated with talented professionals, including Rama Ali Abu Shmeis and James Kowalski. These collaborations have fostered a creative environment that encourages the development of groundbreaking pharmaceutical technologies.

Conclusion

Lakshman Jayanth Parthiban is a dedicated inventor whose work in pharmaceutical formulations is making a significant impact in the healthcare industry. His innovative approaches are paving the way for more effective treatments and improved patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…